BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Vestergaard P, Mosekilde L. Fracture risk in patients with celiac Disease, Crohn's disease, and ulcerative colitis: a nationwide follow-up study of 16,416 patients in Denmark. Am J Epidemiol. 2002;156:1-10. [PMID: 12076883 DOI: 10.1093/aje/kwf007] [Cited by in Crossref: 225] [Cited by in F6Publishing: 209] [Article Influence: 11.3] [Reference Citation Analysis]
Number Citing Articles
1 Lewis NR, Scott BB. Should patients with coeliac disease have their bone mineral density measured. Eur J Gastroenterol Hepatol. 2005;17:1065-1070. [PMID: 16148551 DOI: 10.1097/00042737-200510000-00009] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 1.7] [Reference Citation Analysis]
2 Vestergaard P, Rejnmark L, Mosekilde L. Influence of Hyper- and Hypothyroidism, and the Effects of Treatment with Antithyroid Drugs and Levothyroxine on Fracture Risk. Calcif Tissue Int 2005;77:139-44. [DOI: 10.1007/s00223-005-0068-x] [Cited by in Crossref: 87] [Cited by in F6Publishing: 66] [Article Influence: 5.1] [Reference Citation Analysis]
3 Veerappan SG, O’Morain CA, Daly JS, Ryan BM. Review article: the effects of antitumour necrosis factor-α on bone metabolism in inflammatory bowel disease. Aliment Pharmacol Ther. 2011;33:1261-1272. [PMID: 21521250 DOI: 10.1111/j.1365-2036.2011.04667.x] [Cited by in Crossref: 47] [Cited by in F6Publishing: 44] [Article Influence: 4.3] [Reference Citation Analysis]
4 Franchimont N, Putzeys V, Collette J, Vermeire S, Rutgeerts P, De Vos M, Van Gossum A, Franchimont D, Fiasse R, Pelckmans P, Malaise M, Belaiche J, Louis E. Rapid improvement of bone metabolism after infliximab treatment in Crohn's disease. Aliment Pharmacol Ther. 2004;20:607-614. [PMID: 15352908 DOI: 10.1111/j.1365-2036.2004.02152.x] [Cited by in Crossref: 58] [Cited by in F6Publishing: 46] [Article Influence: 3.2] [Reference Citation Analysis]
5 Logan R, West J. Risk of fracture in coeliac disease. Gut 2003;52:1532. [PMID: 12970154 DOI: 10.1136/gut.52.10.1532-a] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
6 Van Bodegraven AA, Peña AS. Treatment of Extraintestinal Manifestations in Inflammatory Bowel Disease. Curr Treat Options Gastroenterol 2003;6:201-12. [PMID: 12744820 DOI: 10.1007/s11938-003-0002-0] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.5] [Reference Citation Analysis]
7 Rejnmark L, Vestergaard P, Mosekilde L. Treatment with beta-blockers, ACE inhibitors, and calcium-channel blockers is associated with a reduced fracture risk: a nationwide case–control study. Journal of Hypertension 2006;24:581-9. [DOI: 10.1097/01.hjh.0000203845.26690.cb] [Cited by in Crossref: 150] [Cited by in F6Publishing: 127] [Article Influence: 9.4] [Reference Citation Analysis]
8 Trabelsi AB, Abdellaoui F, Ksiaa M, Souguir A, Zeglaoui H, Ben Rejeb M, Brahem A, Ajmi S, Jmaa A. [The decrease in bone density in chronic inflammatory bowel disease: prevalence and risk factors]. Pan Afr Med J 2013;15:70. [PMID: 24198872 DOI: 10.11604/pamj.2013.15.70.2859] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
9 Vestergaard P, Rejnmark L, Mosekilde L. Fracture risk in patients with different types of cancer. Acta Oncologica 2009;48:105-15. [DOI: 10.1080/02841860802167490] [Cited by in Crossref: 25] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
10 Clowes JA, Riggs BL, Khosla S. The role of the immune system in the pathophysiology of osteoporosis. Immunol Rev. 2005;208:207-227. [PMID: 16313351 DOI: 10.1111/j.0105-2896.2005.00334.x] [Cited by in Crossref: 229] [Cited by in F6Publishing: 212] [Article Influence: 14.3] [Reference Citation Analysis]
11 Kappelman MD, Galanko JA, Porter CQ, Sandler RS. Risk of diagnosed fractures in children with inflammatory bowel diseases. Inflamm Bowel Dis 2011;17:1125-30. [PMID: 20872833 DOI: 10.1002/ibd.21472] [Cited by in Crossref: 38] [Cited by in F6Publishing: 24] [Article Influence: 3.2] [Reference Citation Analysis]
12 Briot K, Abitbol V, Roux C. Os et intestin. Prise en charge des ostéopathies associées aux pathologies intestinales. Revue du Rhumatisme Monographies 2016;83:261-5. [DOI: 10.1016/j.monrhu.2016.05.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
13 Capriles VD, Martini LA, Arêas JA. Metabolic osteopathy in celiac disease: importance of a gluten-free diet. Nutr Rev 2009;67:599-606. [PMID: 19785691 DOI: 10.1111/j.1753-4887.2009.00232.x] [Cited by in Crossref: 32] [Cited by in F6Publishing: 27] [Article Influence: 2.5] [Reference Citation Analysis]
14 Orchard T. Extraintestinal complications of inflammatory bowel disease. Curr Gastroenterol Rep. 2003;5:512-517. [PMID: 14602062 DOI: 10.1007/s11894-003-0042-6] [Cited by in Crossref: 36] [Cited by in F6Publishing: 32] [Article Influence: 2.0] [Reference Citation Analysis]
15 van Bodegraven AA, Bravenboer N. Perspective on skeletal health in inflammatory bowel disease. Osteoporos Int 2020;31:637-46. [PMID: 31822927 DOI: 10.1007/s00198-019-05234-w] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
16 Krela-Kaźmierczak I, Skrzypczak-Zielińska M, Kaczmarek-Ryś M, Michalak M, Szymczak-Tomczak A, Hryhorowicz ST, Szalata M, Łykowska-Szuber L, Eder P, Stawczyk-Eder K, Tomczak M, Słomski R, Dobrowolska A. ESR1 Gene Variants Are Predictive of Osteoporosis in Female Patients with Crohn's Disease. J Clin Med 2019;8:E1306. [PMID: 31450614 DOI: 10.3390/jcm8091306] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
17 Larussa T, Suraci E, Nazionale I, Abenavoli L, Imeneo M, Luzza F. Bone mineralization in celiac disease. Gastroenterol Res Pract 2012;2012:198025. [PMID: 22737164 DOI: 10.1155/2012/198025] [Cited by in Crossref: 35] [Cited by in F6Publishing: 29] [Article Influence: 3.5] [Reference Citation Analysis]
18 Siffledeen JS, Fedorak RN, Siminoski K, Jen H, Vaudan E, Abraham N, Seinhart H, Greenberg G. Bones and Crohn's: risk factors associated with low bone mineral density in patients with Crohn's disease. Inflamm Bowel Dis. 2004;10:220-228. [PMID: 15290915 DOI: 10.1097/00054725-200405000-00007] [Cited by in Crossref: 58] [Cited by in F6Publishing: 53] [Article Influence: 3.2] [Reference Citation Analysis]
19 Vestergaard P, Rejnmark L, Mosekilde L. Risk of fractures associated with treatment for benign prostate hyperplasia in men. Osteoporos Int 2011;22:731-7. [DOI: 10.1007/s00198-010-1320-4] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
20 Van staa T, Cooper C, Samuels Brusse L, Leufkens H, Javaid MK, Arden NK. Inflammatory bowel disease and the risk of fracture. Gastroenterology 2003;125:1591-7. [DOI: 10.1053/j.gastro.2003.09.027] [Cited by in Crossref: 174] [Cited by in F6Publishing: 148] [Article Influence: 9.2] [Reference Citation Analysis]
21 Targownik LE, Bernstein CN, Leslie WD. Inflammatory bowel disease and the risk of osteoporosis and fracture. Maturitas. 2013;76:315-319. [PMID: 24139749 DOI: 10.1016/j.maturitas.2013.09.009] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 2.6] [Reference Citation Analysis]
22 Jensen MH, Dethlefsen C, Hejlesen O, Vestergaard P. Association of severe hypoglycemia with mortality for people with diabetes mellitus during a 20-year follow-up in Denmark: a cohort study. Acta Diabetol 2020;57:549-58. [PMID: 31754819 DOI: 10.1007/s00592-019-01447-x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 2.7] [Reference Citation Analysis]
23 Płudowski P, Karczmarewicz E, Socha J, Matusik H, Syczewska M, Lorenc RS. Skeletal and Muscular Status in Juveniles With GFD Treated Clinical and Newly Diagnosed Atypical Celiac Disease—Preliminary Data. Journal of Clinical Densitometry 2007;10:76-85. [DOI: 10.1016/j.jocd.2006.10.005] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
24 Händel MN, Frederiksen P, Osmond C, Cooper C, Abrahamsen B, Heitmann BL. Prenatal exposure to vitamin D from fortified margarine and risk of fractures in late childhood: period and cohort results from 222 000 subjects in the D-tect observational study. Br J Nutr 2017;117:872-81. [PMID: 28393739 DOI: 10.1017/S000711451700071X] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
25 Lichtenstein GR, Sands BE, Pazianas M. Prevention and treatment of osteoporosis in inflammatory bowel disease. Inflamm Bowel Dis. 2006;12:797-813. [PMID: 16917235 DOI: 10.1097/00054725-200608000-00016] [Cited by in Crossref: 59] [Cited by in F6Publishing: 50] [Article Influence: 3.7] [Reference Citation Analysis]
26 van Hogezand RA, Bänffer D, Zwinderman AH, Mccloskey EV, Griffioen G, Hamdy NAT. Ileum resection is the most predictive factor for osteoporosis in patients with Crohn’s disease. Osteoporos Int 2006;17:535-42. [DOI: 10.1007/s00198-005-0016-7] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 1.4] [Reference Citation Analysis]
27 Abreu MT, Kantorovich V, Vasiliauskas EA, Gruntmanis U, Matuk R, Daigle K, Chen S, Zehnder D, Lin YC, Yang H. Measurement of vitamin D levels in inflammatory bowel disease patients reveals a subset of Crohn’s disease patients with elevated 1,25-dihydroxyvitamin D and low bone mineral density. Gut. 2004;53:1129-1136. [PMID: 15247180 DOI: 10.1136/gut.2003.036657] [Cited by in Crossref: 138] [Cited by in F6Publishing: 120] [Article Influence: 7.7] [Reference Citation Analysis]
28 Bartko J, Reichardt B, Kocijan R, Klaushofer K, Zwerina J, Behanova M. Inflammatory Bowel Disease: A Nationwide Study of Hip Fracture and Mortality Risk After Hip Fracture. Journal of Crohn's and Colitis 2020;14:1256-63. [DOI: 10.1093/ecco-jcc/jjaa052] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
29 Okayasu M, Ogata H, Yoshiyama Y. Use of corticosteroids for remission induction therapy in patients with new-onset ulcerative colitis in real-world settings. J Mark Access Health Policy 2019;7:1565889. [PMID: 30719244 DOI: 10.1080/20016689.2019.1565889] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
30 Zali M, Bahari A, Firouzi F, Daryani NE, Aghazadeh R, Emam MM, Rezaie A, Shalmani HM, Naderi N, Maleki B. Bone mineral density in Iranian patients with inflammatory bowel disease. Int J Colorectal Dis. 2006;21:758-766. [PMID: 16463035 DOI: 10.1007/s00384-005-0084-3] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 0.6] [Reference Citation Analysis]
31 Abrahamsen B, Vestergaard P. Proton pump inhibitor use and fracture risk — effect modification by histamine H1 receptor blockade. Observational case–control study using National Prescription Data. Bone 2013;57:269-71. [DOI: 10.1016/j.bone.2013.08.013] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 3.2] [Reference Citation Analysis]
32 Bernstein CN, Leslie WD, Taback SP. Bone density in a population-based cohort of premenopausal adult women with early onset inflammatory bowel disease. Am J Gastroenterol. 2003;98:1094-1100. [PMID: 12809833 DOI: 10.1111/j.1572-0241.2003.07415.x] [Cited by in Crossref: 43] [Cited by in F6Publishing: 31] [Article Influence: 2.3] [Reference Citation Analysis]
33 Emkey GR, Epstein S. Secondary osteoporosis: Pathophysiology & diagnosis. Best Practice & Research Clinical Endocrinology & Metabolism 2014;28:911-35. [DOI: 10.1016/j.beem.2014.07.002] [Cited by in Crossref: 36] [Cited by in F6Publishing: 25] [Article Influence: 4.5] [Reference Citation Analysis]
34 Schwartz J. The effects of particulate air pollution on daily deaths: a multi-city case crossover analysis. Occup Environ Med 2004;61:956-61. [PMID: 15550600 DOI: 10.1136/oem.2003.008250] [Cited by in Crossref: 94] [Cited by in F6Publishing: 85] [Article Influence: 5.2] [Reference Citation Analysis]
35 Rubin KH, Rothmann MJ, Holmberg T, Høiberg M, Möller S, Barkmann R, Glüer CC, Hermann AP, Bech M, Gram J, Brixen K. Effectiveness of a two-step population-based osteoporosis screening program using FRAX: the randomized Risk-stratified Osteoporosis Strategy Evaluation (ROSE) study. Osteoporos Int 2018;29:567-78. [DOI: 10.1007/s00198-017-4326-3] [Cited by in Crossref: 45] [Cited by in F6Publishing: 34] [Article Influence: 9.0] [Reference Citation Analysis]
36 Bernstein CN, Sargent M, Leslie WD. Serum Osteoprotegerin Is Increased in Crohnʼs Disease: a Population-Based Case Control Study: . Inflammatory Bowel Diseases 2005;11:325-30. [DOI: 10.1097/01.mib.0000164015.60795.ca] [Cited by in Crossref: 47] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
37 Lee N, Radford-Smith GL, Forwood M, Wong J, Taaffe DR. Body composition and muscle strength as predictors of bone mineral density in Crohn’s disease. J Bone Miner Metab. 2009;27:456-463. [PMID: 19333683 DOI: 10.1007/s00774-009-0059-5] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 1.8] [Reference Citation Analysis]
38 Navaneethan U, Shen L, Venkatesh PG, Hammel J, Patel V, Remzi FH, Kiran RP. Influence of ileal pouch anal anastomosis on bone loss in ulcerative colitis patients. J Crohns Colitis. 2011;5:415-422. [PMID: 21939915 DOI: 10.1016/j.crohns.2011.04.008] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 1.5] [Reference Citation Analysis]
39 Karve S, Candrilli S, Kappelman MD, Tolleson-Rinehart S, Tennis P, Andrews E. Healthcare utilization and comorbidity burden among children and young adults in the United States with systemic lupus erythematosus or inflammatory bowel disease. J Pediatr 2012;161:662-670.e2. [PMID: 22578787 DOI: 10.1016/j.jpeds.2012.03.045] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 2.3] [Reference Citation Analysis]
40 Rejnmark L, Vestergaard P, Mosekilde L. Decreased fracture risk in users of organic nitrates: a nationwide case-control study. J Bone Miner Res 2006;21:1811-7. [PMID: 17054422 DOI: 10.1359/jbmr.060804] [Cited by in Crossref: 51] [Cited by in F6Publishing: 39] [Article Influence: 3.4] [Reference Citation Analysis]
41 Rodríguez-Bores L, Barahona-Garrido J, Yamamoto-Furusho JK. Basic and clinical aspects of osteoporosis in inflammatory bowel disease. World J Gastroenterol 2007; 13(46): 6156-6165 [PMID: 18069754 DOI: 10.3748/wjg.v13.i46.6156] [Cited by in CrossRef: 25] [Cited by in F6Publishing: 23] [Article Influence: 1.7] [Reference Citation Analysis]
42 Hansen L, Mathiesen AS, Vestergaard P, Ehlers LH, Petersen KD. A health economic analysis of osteoporotic fractures: who carries the burden? Arch Osteoporos 2013;8:126. [PMID: 23420317 DOI: 10.1007/s11657-013-0126-3] [Cited by in Crossref: 37] [Cited by in F6Publishing: 33] [Article Influence: 4.1] [Reference Citation Analysis]
43 Kruse C, Eiken P, Vestergaard P. Machine Learning Principles Can Improve Hip Fracture Prediction. Calcif Tissue Int 2017;100:348-60. [PMID: 28197643 DOI: 10.1007/s00223-017-0238-7] [Cited by in Crossref: 32] [Cited by in F6Publishing: 27] [Article Influence: 6.4] [Reference Citation Analysis]
44 Loftus EV Jr. Management of extraintestinal manifestations and other complications of inflammatory bowel disease. Curr Gastroenterol Rep. 2004;6:506-513. [PMID: 15527681 DOI: 10.1007/s11894-004-0073-7] [Cited by in Crossref: 46] [Cited by in F6Publishing: 34] [Article Influence: 2.6] [Reference Citation Analysis]
45 Corazza GR, Di Stefano M, Mauriño E, Bai JC. Bones in coeliac disease: diagnosis and treatment. Best Pract Res Clin Gastroenterol 2005;19:453-65. [PMID: 15925849 DOI: 10.1016/j.bpg.2005.01.002] [Cited by in Crossref: 45] [Cited by in F6Publishing: 46] [Article Influence: 2.6] [Reference Citation Analysis]
46 Zatorski H, Marynowski M, Fichna J. Is insulin-like growth factor 1 (IGF-1) system an attractive target inflammatory bowel diseases? Benefits and limitation of potential therapy. Pharmacol Rep 2016;68:809-15. [PMID: 27117379 DOI: 10.1016/j.pharep.2016.03.006] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
47 Vestergaard P, Rejnmark L, Mosekilde L. Fracture reducing potential of hormone replacement therapy on a population level. Maturitas 2006;54:285-93. [DOI: 10.1016/j.maturitas.2005.12.004] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
48 Card T, West J, Hubbard R, Logan RF. Hip fractures in patients with inflammatory bowel disease and their relationship to corticosteroid use: a population based cohort study. Gut. 2004;53:251-255. [PMID: 14724159 DOI: 10.1136/gut.2003.026799] [Cited by in Crossref: 102] [Cited by in F6Publishing: 95] [Article Influence: 5.7] [Reference Citation Analysis]
49 Rubin KH, Abrahamsen B, Friis-holmberg T, Hjelmborg JV, Bech M, Hermann AP, Barkmann R, Glüer CC, Brixen K. Comparison of different screening tools (FRAX®, OST, ORAI, OSIRIS, SCORE and age alone) to identify women with increased risk of fracture. A population-based prospective study. Bone 2013;56:16-22. [DOI: 10.1016/j.bone.2013.05.002] [Cited by in Crossref: 58] [Cited by in F6Publishing: 43] [Article Influence: 6.4] [Reference Citation Analysis]
50 Jennings JSR, Howdle PD. New developments in celiac disease: . Current Opinion in Gastroenterology 2003;19:118-29. [DOI: 10.1097/00001574-200303000-00004] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
51 Loftus EV Jr, Achenbach SJ, Sandborn WJ, Tremaine WJ, Oberg AL, Melton LJ 3rd. Risk of fracture in ulcerative colitis: a population-based study from Olmsted County, Minnesota. Clin Gastroenterol Hepatol. 2003;1:465-473. [PMID: 15017646 DOI: 10.1016/s1542-3565(03)00185-x] [Cited by in Crossref: 50] [Cited by in F6Publishing: 21] [Article Influence: 2.8] [Reference Citation Analysis]
52 Vestergaard P, Rejnmark L, Mosekilde L. Fracture risk associated with use of nonsteroidal anti-inflammatory drugs, acetylsalicylic acid, and acetaminophen and the effects of rheumatoid arthritis and osteoarthritis. Calcif Tissue Int 2006;79:84-94. [PMID: 16927048 DOI: 10.1007/s00223-006-0020-8] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 1.9] [Reference Citation Analysis]
53 Bernstein CN, Leslie WD, Leboff MS. AGA technical review on osteoporosis in gastrointestinal diseases. Gastroenterology. 2003;124:795-841. [PMID: 12612917 DOI: 10.1053/gast.2003.50106] [Cited by in Crossref: 264] [Cited by in F6Publishing: 215] [Article Influence: 13.9] [Reference Citation Analysis]
54 Vestergaard P, Rejnmark L, Mosekilde L. Fracture risk associated with the use of morphine and opiates. J Intern Med. 2006;260:76-87. [PMID: 16789982 DOI: 10.1111/j.1365-2796.2006.01667.x] [Cited by in Crossref: 160] [Cited by in F6Publishing: 147] [Article Influence: 10.0] [Reference Citation Analysis]
55 van Hogezand RA, Hamdy NA. Skeletal morbidity in inflammatory bowel disease. Scand J Gastroenterol Suppl. 2006;59-64. [PMID: 16782623 DOI: 10.1080/00365520600664276] [Cited by in Crossref: 46] [Cited by in F6Publishing: 45] [Article Influence: 3.1] [Reference Citation Analysis]
56 Vestergaard P, Rejnmark L, Mosekilde L. Effect of tamoxifen and aromatase inhibitors on the risk of fractures in women with breast cancer. Calcif Tissue Int 2008;82:334-40. [PMID: 18463912 DOI: 10.1007/s00223-008-9132-7] [Cited by in Crossref: 30] [Cited by in F6Publishing: 23] [Article Influence: 2.1] [Reference Citation Analysis]
57 Vestergaard P, Rejnmark L, Mosekilde L. Oral contraceptive use and risk of fractures. Contraception 2006;73:571-6. [DOI: 10.1016/j.contraception.2006.01.006] [Cited by in Crossref: 30] [Cited by in F6Publishing: 22] [Article Influence: 1.9] [Reference Citation Analysis]
58 Serrano-montalbán B, Arias Á, Friginal-ruiz AB, Lucendo AJ. The Use of the Fracture Risk Assessment (FRAX®) Tool in Predicting Risk of Fractures in Patients With Inflammatory Bowel Disease: A Systematic Review. Journal of Clinical Densitometry 2017;20:180-7. [DOI: 10.1016/j.jocd.2016.08.010] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
59 Thomason K, West J, Logan RF, Coupland C, Holmes GK. Fracture experience of patients with coeliac disease: a population based survey. Gut 2003;52:518-22. [PMID: 12631662 DOI: 10.1136/gut.52.4.518] [Cited by in Crossref: 79] [Cited by in F6Publishing: 66] [Article Influence: 4.2] [Reference Citation Analysis]
60 Holmberg T, Möller S, Rothmann M, Gram J, Herman A, Brixen K, Tolstrup J, Høiberg M, Bech M, Rubin K. Socioeconomic status and risk of osteoporotic fractures and the use of DXA scans: data from the Danish population-based ROSE study. Osteoporos Int 2019;30:343-53. [DOI: 10.1007/s00198-018-4768-2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
61 Olmos M, Antelo M, Vazquez H, Smecuol E, Mauriño E, Bai JC. Systematic review and meta-analysis of observational studies on the prevalence of fractures in coeliac disease. Dig Liver Dis 2008;40:46-53. [PMID: 18006396 DOI: 10.1016/j.dld.2007.09.006] [Cited by in Crossref: 108] [Cited by in F6Publishing: 95] [Article Influence: 7.2] [Reference Citation Analysis]
62 Abreu MT, Geller JL, Vasiliauskas EA, Kam LY, Vora P, Martyak LA, Yang H, Hu B, Lin YC, Keenan G. Treatment with infliximab is associated with increased markers of bone formation in patients with Crohn’s disease. J Clin Gastroenterol. 2006;40:55-63. [PMID: 16340635 DOI: 10.1097/01.mcg.0000190762.80615.d4] [Cited by in Crossref: 61] [Cited by in F6Publishing: 50] [Article Influence: 3.8] [Reference Citation Analysis]
63 Ludvigsson JF, Mahl M, Sachs MC, Björk J, Michaelsson K, Ekbom A, Askling J, Backman AS, Olén O. Fracture Risk in Patients With Inflammatory Bowel Disease: A Nationwide Population-Based Cohort Study From 1964 to 2014. Am J Gastroenterol 2019;114:291-304. [PMID: 30730858 DOI: 10.14309/ajg.0000000000000062] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 5.7] [Reference Citation Analysis]
64 Prieto-Alhambra D, Muñoz-Ortego J, De Vries F, Vosse D, Arden NK, Bowness P, Cooper C, Diez-Perez A, Vestergaard P. Ankylosing spondylitis confers substantially increased risk of clinical spine fractures: a nationwide case-control study. Osteoporos Int 2015;26:85-91. [PMID: 25341971 DOI: 10.1007/s00198-014-2939-3] [Cited by in Crossref: 47] [Cited by in F6Publishing: 38] [Article Influence: 5.9] [Reference Citation Analysis]
65 Hjelle AM, Apalset E, Mielnik P, Bollerslev J, Lundin KEA, Tell GS. Celiac disease and risk of fracture in adults—a review. Osteoporos Int 2014;25:1667-76. [DOI: 10.1007/s00198-014-2683-8] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.9] [Reference Citation Analysis]
66 Bazelier MT, Bentzen J, Vestergaard P, Stenager E, Leufkens HG, van Staa T, de Vries F. The risk of fracture in incident multiple sclerosis patients: The Danish National Health Registers. Mult Scler 2012;18:1609-16. [DOI: 10.1177/1352458512442755] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 1.9] [Reference Citation Analysis]
67 Pasternack C, Koskinen I, Hervonen K, Kaukinen K, Järvelin J, Reunala T, Collin P, Huhtala H, Mattila VM, Salmi T. Risk of fractures in dermatitis herpetiformis and coeliac disease: a register-based study. Scand J Gastroenterol 2019;54:843-8. [PMID: 31280614 DOI: 10.1080/00365521.2019.1636132] [Cited by in Crossref: 3] [Article Influence: 1.0] [Reference Citation Analysis]
68 Rejnmark L, Vestergaard P, Mosekilde L. Statin but not Non-Statin Lipid-Lowering Drugs Decrease Fracture Risk: A Nation-Wide Case-Control Study. Calcif Tissue Int 2006;79:27-36. [DOI: 10.1007/s00223-006-0024-4] [Cited by in Crossref: 39] [Cited by in F6Publishing: 32] [Article Influence: 2.4] [Reference Citation Analysis]
69 Arden NK, Cooper C. Assessment of the risk of fracture in patients with gastrointestinal disease. Eur J Gastroenterol Hepatol 2003;15:865-8. [PMID: 12867795 DOI: 10.1097/00042737-200308000-00005] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
70 Levin AD, Wadhera V, Leach ST, Woodhead HJ, Lemberg DA, Mendoza-Cruz AC, Day AS. Vitamin D deficiency in children with inflammatory bowel disease. Dig Dis Sci. 2011;56:830-836. [PMID: 21222159 DOI: 10.1007/s10620-010-1544-3] [Cited by in Crossref: 102] [Cited by in F6Publishing: 96] [Article Influence: 9.3] [Reference Citation Analysis]
71 Tignor AS, Wu BU, Whitlock TL, Lopez R, Repas K, Banks PA, Conwell D. High prevalence of low-trauma fracture in chronic pancreatitis. Am J Gastroenterol. 2010;105:2680-2686. [PMID: 20736937 DOI: 10.1038/ajg.2010.325] [Cited by in Crossref: 71] [Cited by in F6Publishing: 58] [Article Influence: 5.9] [Reference Citation Analysis]
72 Briot K, Geusens P, Em Bultink I, Lems WF, Roux C. Inflammatory diseases and bone fragility. Osteoporos Int. 2017;28:3301-3314. [PMID: 28916915 DOI: 10.1007/s00198-017-4189-7] [Cited by in Crossref: 69] [Cited by in F6Publishing: 52] [Article Influence: 13.8] [Reference Citation Analysis]
73 Jørgensen NR, Schwarz P, Iversen HK, Vestergaard P. P2Y12 Receptor Antagonist, Clopidogrel, Does Not Contribute to Risk of Osteoporotic Fractures in Stroke Patients. Front Pharmacol 2017;8:821. [PMID: 29204116 DOI: 10.3389/fphar.2017.00821] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
74 Komaki Y, Komaki F, Micic D, Ido A, Sakuraba A. Risk of Fractures in Inflammatory Bowel Diseases: A Systematic Review and Meta-Analysis. J Clin Gastroenterol. 2019;53:441-448. [PMID: 29672437 DOI: 10.1097/mcg.0000000000001031] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 5.5] [Reference Citation Analysis]
75 Frederiksen A, Abrahamsen B, Johansen PB, Sørensen HA. Danish, national cross-sectional observational study on the prevalence of prior major osteoporotic fractures in adults presenting with hip fracture-limitations and scope for fracture liaison services in prevention of hip fracture. Osteoporos Int 2018;29:109-14. [PMID: 28965215 DOI: 10.1007/s00198-017-4247-1] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
76 García-Manzanares A, Tenias JM, Lucendo AJ. Bone mineral density directly correlates with duodenal Marsh stage in newly diagnosed adult celiac patients. Scand J Gastroenterol 2012;47:927-36. [PMID: 22587226 DOI: 10.3109/00365521.2012.688217] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 2.4] [Reference Citation Analysis]
77 Ludvigsson JF, Michaelsson K, Ekbom A, Montgomery SM. Coeliac disease and the risk of fractures - a general population-based cohort study. Aliment Pharmacol Ther 2007;25:273-85. [PMID: 17269989 DOI: 10.1111/j.1365-2036.2006.03203.x] [Cited by in Crossref: 98] [Cited by in F6Publishing: 80] [Article Influence: 6.5] [Reference Citation Analysis]
78 Vestergaard P, Rejnmark L, Mosekilde L. Methotrexate, azathioprine, cyclosporine, and risk of fracture. Calcif Tissue Int 2006;79:69-75. [PMID: 16927044 DOI: 10.1007/s00223-006-0060-0] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 1.3] [Reference Citation Analysis]
79 Jensen MH, Vestergaard P. Hypoglycaemia and type 1 diabetes are associated with an increased risk of fractures. Osteoporos Int 2019;30:1663-70. [DOI: 10.1007/s00198-019-05014-6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
80 van Heel DA, West J. Recent advances in coeliac disease. Gut. 2006;55:1037-1046. [PMID: 16766754 DOI: 10.1136/gut.2005.075119] [Cited by in Crossref: 179] [Cited by in F6Publishing: 146] [Article Influence: 11.2] [Reference Citation Analysis]
81 Todhunter CE, Sutherland-Craggs A, Bartram SA, Donaldson PT, Daly AK, Francis RM, Mansfield JC, Thompson NP. Influence of IL-6, COL1A1, and VDR gene polymorphisms on bone mineral density in Crohn's disease. Gut. 2005;54:1579-1584. [PMID: 16009674 DOI: 10.1136/gut.2005.064212] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 1.5] [Reference Citation Analysis]
82 Holm JP, Hyldstrup L, Jensen JB. Time trends in osteoporosis risk factor profiles: a comparative analysis of risk factors, comorbidities, and medications over twelve years. Endocrine 2016;54:241-55. [PMID: 27178283 DOI: 10.1007/s12020-016-0987-5] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.7] [Reference Citation Analysis]
83 Etzel JP, Larson MF, Anawalt BD, Collins J, Dominitz JA. Assessment and management of low bone density in inflammatory bowel disease and performance of professional society guidelines. Inflamm Bowel Dis. 2011;17:2122-2129. [PMID: 21910174 DOI: 10.1002/ibd.21601] [Cited by in Crossref: 38] [Cited by in F6Publishing: 36] [Article Influence: 3.5] [Reference Citation Analysis]
84 Dickey W. Symposium 1: Joint BAPEN and British Society of Gastroenterology Symposium on ‘Coeliac disease: basics and controversies’ Coeliac disease in the twenty-first century: Conference on ‘Malnutrition matters’. Proc Nutr Soc 2009;68:234-41. [DOI: 10.1017/s0029665109001414] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
85 Hjelle AM, Apalset E, Mielnik P, Nilsen RM, Lundin KEA, Tell GS. Positive IgA against transglutaminase 2 in patients with distal radius and ankle fractures compared to community-based controls. Scand J Gastroenterol 2018;53:1212-6. [PMID: 30265163 DOI: 10.1080/00365521.2018.1509122] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
86 Cranney A, Rostom A, Sy R, Dubé C, Saloogee N, Garritty C, Moher D, Sampson M, Zhang L, Yazdi F, Mamaladze V, Pan I, MacNeil J. Consequences of testing for celiac disease. Gastroenterology 2005;128:S109-20. [PMID: 15825118 DOI: 10.1053/j.gastro.2005.02.019] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 1.3] [Reference Citation Analysis]
87 Chedid VG, Kane SV. Bone Health in Patients With Inflammatory Bowel Diseases. Journal of Clinical Densitometry 2020;23:182-9. [DOI: 10.1016/j.jocd.2019.07.009] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
88 Petersen SB, Strøm M, Maslova E, Granström C, Vestergaard P, Mølgaard C, Olsen SF. Predicted vitamin D status during pregnancy in relation to offspring forearm fractures in childhood: a study from the Danish National Birth Cohort. Br J Nutr 2015;114:1900-8. [DOI: 10.1017/s000711451500361x] [Cited by in Crossref: 10] [Article Influence: 1.4] [Reference Citation Analysis]
89 Pantaleoni S, Luchino M, Adriani A, Pellicano R, Stradella D, Ribaldone DG, Sapone N, Isaia GC, Di Stefano M, Astegiano M. Bone mineral density at diagnosis of celiac disease and after 1 year of gluten-free diet. ScientificWorldJournal. 2014;2014:173082. [PMID: 25379519 DOI: 10.1155/2014/173082] [Cited by in Crossref: 30] [Cited by in F6Publishing: 24] [Article Influence: 3.8] [Reference Citation Analysis]
90 Eivindson M, Nielsen JN, Grønbaek H, Flyvbjerg A, Hey H. The insulin-like growth factor system and markers of inflammation in adult patients with inflammatory bowel disease. Horm Res 2005;64:9-15. [PMID: 16088202 DOI: 10.1159/000087190] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 1.2] [Reference Citation Analysis]
91 Vestergaard P, Rejnmark L, Mosekilde L. Increased mortality in patients with a hip fracture-effect of pre-morbid conditions and post-fracture complications. Osteoporos Int 2007;18:1583-93. [PMID: 17566814 DOI: 10.1007/s00198-007-0403-3] [Cited by in Crossref: 207] [Cited by in F6Publishing: 190] [Article Influence: 13.8] [Reference Citation Analysis]
92 Targownik LE, Bernstein CN, Leslie WD. Risk factors and management of osteoporosis in inflammatory bowel disease. Curr Opin Gastroenterol. 2014;30:168-174. [PMID: 24419292 DOI: 10.1097/mog.0000000000000037] [Cited by in Crossref: 41] [Cited by in F6Publishing: 19] [Article Influence: 5.1] [Reference Citation Analysis]
93 Vestergaard P, Rejnmark L, Mosekilde L. Osteoporosis is markedly underdiagnosed: a nationwide study from Denmark. Osteoporos Int. 2005;16:134-141. [PMID: 15197546 DOI: 10.1007/s00198-004-1680-8] [Cited by in Crossref: 137] [Cited by in F6Publishing: 139] [Article Influence: 7.6] [Reference Citation Analysis]
94 Vestergaard P, Rejnmark L, Mosekilde L. Reduced relative risk of fractures among users of lithium. Calcif Tissue Int 2005;77:1-8. [PMID: 16007481 DOI: 10.1007/s00223-004-0258-y] [Cited by in Crossref: 77] [Cited by in F6Publishing: 66] [Article Influence: 4.5] [Reference Citation Analysis]
95 Driessen JH, van Onzenoort HA, Starup-Linde J, Henry R, Burden AM, Neef C, van den Bergh JP, Vestergaard P, de Vries F. Use of Glucagon-Like-Peptide 1 Receptor Agonists and Risk of Fracture as Compared to Use of Other Anti-hyperglycemic Drugs. Calcif Tissue Int. 2015;97:506-515. [PMID: 26184119 DOI: 10.1007/s00223-015-0037-y] [Cited by in Crossref: 39] [Cited by in F6Publishing: 29] [Article Influence: 5.6] [Reference Citation Analysis]
96 Tran T, Bliuc D, Hansen L, Abrahamsen B, van den Bergh J, Eisman JA, van Geel T, Geusens P, Vestergaard P, Nguyen TV, Center JR. Persistence of Excess Mortality Following Individual Nonhip Fractures: A Relative Survival Analysis. J Clin Endocrinol Metab 2018;103:3205-14. [PMID: 30053007 DOI: 10.1210/jc.2017-02656] [Cited by in Crossref: 28] [Cited by in F6Publishing: 22] [Article Influence: 9.3] [Reference Citation Analysis]
97 Vestergaard P, Rejnmark L, Mosekilde L. Fracture risk in very young women using combined oral contraceptives. Contraception 2008;78:358-64. [PMID: 18929731 DOI: 10.1016/j.contraception.2008.06.010] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
98 Ramsey-goldman R. Missed opportunities in physician management of glucocorticoid-induced osteoporosis? Arthritis & Rheumatism 2002;46:3115-20. [DOI: 10.1002/art.10619] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 1.2] [Reference Citation Analysis]
99 Skowro??ska-j????wiak E, Lorenc RS. Metabolic Bone Disease in Children: Etiology and Treatment Options. Treatments in Endocrinology 2006;5:297-318. [DOI: 10.2165/00024677-200605050-00004] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
100 Bernstein CN, Leslie WD. Osteoporosis and inflammatory bowel disease: REVIEW: OSTEOPOROSIS AND INFLAMMATORY BOWEL DISEASE. Alimentary Pharmacology & Therapeutics 2004;19:941-52. [DOI: 10.1111/j.1365-2036.2004.01876.x] [Cited by in Crossref: 47] [Cited by in F6Publishing: 38] [Article Influence: 2.6] [Reference Citation Analysis]
101 Nygaard L, Skallerup A, Olesen SS, Køhler M, Vinter-jensen L, Kruse C, Vestergaard P, Rasmussen HH. Osteoporosis in patients with intestinal insufficiency and intestinal failure: Prevalence and clinical risk factors. Clinical Nutrition 2018;37:1654-60. [DOI: 10.1016/j.clnu.2017.07.018] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
102 Oshagbemi OA, Burden AM, Shudofsky KN, Driessen JH, Vestergaard P, Krings A, Franssen FM, van den Bergh J, de Vries F. Use of high-dose intermittent systemic glucocorticoids and the risk of fracture in patients with chronic obstructive pulmonary disease. Bone 2018;110:238-43. [DOI: 10.1016/j.bone.2018.02.007] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
103 Christensen AM, Brandsborg S, Vestergaard P, Laurberg S. Comparison of fracture risk between patients with ileal pouch-anal anastomosis for ulcerative colitis and the general population. J Crohns Colitis 2014;8:107-12. [PMID: 23871399 DOI: 10.1016/j.crohns.2013.07.001] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
104 Hill RJ, Brookes DS, Davies PS. Bones in pediatric Crohn's disease: a review of fracture risk in children and adults. Inflamm Bowel Dis 2011;17:1223-8. [PMID: 20824813 DOI: 10.1002/ibd.21471] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
105 Vestergaard P, Rejnmark L, Mosekilde L. Fracture Risk Associated with Use of Antiepileptic Drugs. Epilepsia 2004;45:1330-7. [DOI: 10.1111/j.0013-9580.2004.18804.x] [Cited by in Crossref: 167] [Cited by in F6Publishing: 136] [Article Influence: 9.3] [Reference Citation Analysis]
106 Zanobetti A, Schwartz J, Samoli E, Gryparis A, Touloumi G, Peacock J, Anderson RH, Le Tertre A, Bobros J, Celko M, Goren A, Forsberg B, Michelozzi P, Rabczenko D, Hoyos SP, Wichmann HE, Katsouyanni K. The temporal pattern of respiratory and heart disease mortality in response to air pollution. Environ Health Perspect 2003;111:1188-93. [PMID: 12842772 DOI: 10.1289/ehp.5712] [Cited by in Crossref: 184] [Cited by in F6Publishing: 161] [Article Influence: 9.7] [Reference Citation Analysis]
107 Vestergaard P, Steinberg TH, Schwarz P, Jørgensen NR. Use of the oral platelet inhibitors dipyridamole and acetylsalicylic acid is associated with increased risk of fracture. Int J Cardiol 2012;160:36-40. [PMID: 21463909 DOI: 10.1016/j.ijcard.2011.03.026] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 1.7] [Reference Citation Analysis]
108 Vestergaard P, Rejnmark L, Mosekilde L. Hypertension is a risk factor for fractures. Calcif Tissue Int 2009;84:103-11. [PMID: 19067019 DOI: 10.1007/s00223-008-9198-2] [Cited by in Crossref: 91] [Cited by in F6Publishing: 83] [Article Influence: 6.5] [Reference Citation Analysis]
109 Shen B, Remzi FH, Oikonomou IK, Lu H, Lashner BA, Hammel JP, Skugor M, Bennett AE, Brzezinski A, Queener E. Risk factors for low bone mass in patients with ulcerative colitis following ileal pouch-anal anastomosis. Am J Gastroenterol. 2009;104:639-646. [PMID: 19262520 DOI: 10.1038/ajg.2008.78] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 2.0] [Reference Citation Analysis]
110 Tsai MS, Lin CL, Tu YK, Lee PH, Kao CH. Risks and predictors of osteoporosis in patients with inflammatory bowel diseases in an Asian population: a nationwide population-based cohort study. Int J Clin Pract. 2015;69:235-241. [PMID: 25472555 DOI: 10.1111/ijcp.12526] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 3.4] [Reference Citation Analysis]
111 Rejnmark L, Vestergaard P, Mosekilde L. Reduced fracture risk in users of thiazide diuretics. Calcif Tissue Int 2005;76:167-75. [PMID: 15719207 DOI: 10.1007/s00223-004-0084-2] [Cited by in Crossref: 67] [Cited by in F6Publishing: 50] [Article Influence: 3.9] [Reference Citation Analysis]
112 Vestergaard P, Rejnmark L, Mosekilde L. The effects of depot medroxyprogesterone acetate and intrauterine device use on fracture risk in Danish women. Contraception 2008;78:459-64. [DOI: 10.1016/j.contraception.2008.07.014] [Cited by in Crossref: 39] [Cited by in F6Publishing: 28] [Article Influence: 2.8] [Reference Citation Analysis]
113 Faurschou M, Baslund B, Obel N. Pronounced Risk of Fractures among Elderly Men Affected by Granulomatosis with Polyangiitis. J Rheumatol 2015;42:1667-71. [PMID: 26233512 DOI: 10.3899/jrheum.141566] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
114 Bernstein CN. Inflammatory bowel diseases as secondary causes of osteoporosis. Curr Osteoporos Rep 2006;4:116-23. [PMID: 16908001 DOI: 10.1007/s11914-996-0031-4] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 1.1] [Reference Citation Analysis]
115 Sánchez MIP, Mohaidle A, Baistrocchi A, Matoso D, Vázquez H, González A, Mazure R, Maffei E, Ferrari G, Smecuol E, Crivelli A, Paula JA, Gómez JC, Pedreira S, Mauriño E, Bai JC. Risk of fracture in celiac disease: Gender, dietary compliance, or both? World J Gastroenterol 2011; 17(25): 3035-3042 [PMID: 21799650 DOI: 10.3748/wjg.v17.i25.3035] [Cited by in CrossRef: 39] [Cited by in F6Publishing: 33] [Article Influence: 3.5] [Reference Citation Analysis]
116 Goddard CJ, Gillett HR. Complications of coeliac disease: are all patients at risk? Postgrad Med J. 2006;82:705-712. [PMID: 17099088 DOI: 10.1136/pgmj.2006.048876] [Cited by in Crossref: 46] [Cited by in F6Publishing: 36] [Article Influence: 2.9] [Reference Citation Analysis]
117 Ismail MH, Al-Elq AH, Al-Jarodi ME, Azzam NA, Aljebreen AM, Al-Momen SA, Bseiso BF, Al-Mulhim FA, Alquorain A. Frequency of low bone mineral density in Saudi patients with inflammatory bowel disease. Saudi J Gastroenterol. 2012;18:201-207. [PMID: 22626800 DOI: 10.4103/1319-3767.96458] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
118 Siffledeen JS, Siminoski K, Jen H, Fedorak RN. Vertebral fractures and role of low bone mineral density in Crohn's disease. Clin Gastroenterol Hepatol 2007;5:721-8. [PMID: 17482522 DOI: 10.1016/j.cgh.2007.02.024] [Cited by in Crossref: 32] [Cited by in F6Publishing: 24] [Article Influence: 2.1] [Reference Citation Analysis]
119 Vestergaard P, Rejnmark L, Mosekilde L. Anxiolytics and sedatives and risk of fractures: effects of half-life. Calcif Tissue Int 2008;82:34-43. [PMID: 18175030 DOI: 10.1007/s00223-007-9095-0] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 1.7] [Reference Citation Analysis]
120 Ghaly S, Lawrance I. The role of vitamin D in gastrointestinal inflammation. Expert Review of Gastroenterology & Hepatology 2014;8:909-23. [DOI: 10.1586/17474124.2014.925796] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 2.6] [Reference Citation Analysis]
121 Xing Y, Morgan SL. Celiac Disease and Metabolic Bone Disease. Journal of Clinical Densitometry 2013;16:439-44. [DOI: 10.1016/j.jocd.2013.08.012] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
122 Krela-Kaźmierczak I, Wysocka E, Szymczak A, Eder P, Michalak M, Łykowska-Szuber L, Stawczyk-Eder K, Klimczak K, Linke K, Horst-Sikorska W. Osteoprotegerin, s-RANKL, and selected interleukins in the pathology of bone metabolism in patients with Crohn's disease. Prz Gastroenterol 2016;11:30-4. [PMID: 27110308 DOI: 10.5114/pg.2015.52589] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
123 Bianchi ML, Bardella MT. Bone in celiac disease. Osteoporos Int. 2008;19:1705-1716. [PMID: 18418638 DOI: 10.1007/s00198-008-0624-0] [Cited by in Crossref: 82] [Cited by in F6Publishing: 68] [Article Influence: 5.9] [Reference Citation Analysis]
124 Høiberg MP, Gram J, Hermann P, Brixen K, Haugeberg G. The incidence of hip fractures in Norway -accuracy of the national Norwegian patient registry. BMC Musculoskelet Disord 2014;15:372. [PMID: 25394865 DOI: 10.1186/1471-2474-15-372] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 3.3] [Reference Citation Analysis]
125 Pagès-Castellà A, Carbonell-Abella C, Avilés FF, Alzamora M, Baena-Díez JM, Laguna DM, Nogués X, Díez-Pérez A, Prieto-Alhambra D. "Burden of osteoporotic fractures in primary health care in Catalonia (Spain): a population-based study". BMC Musculoskelet Disord 2012;13:79. [PMID: 22639802 DOI: 10.1186/1471-2474-13-79] [Cited by in Crossref: 43] [Cited by in F6Publishing: 38] [Article Influence: 4.3] [Reference Citation Analysis]
126 Viswanathan A, Sylvester FA. Chronic pediatric inflammatory diseases: Effects on bone. Rev Endocr Metab Disord 2008;9:107-22. [DOI: 10.1007/s11154-007-9070-0] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 1.3] [Reference Citation Analysis]
127 Friis-holmberg T, Brixen K, Rubin KH, Grønbæk M, Bech M. Phalangeal bone mineral density predicts incident fractures: a prospective cohort study on men and women—results from the Danish Health Examination Survey 2007–2008 (DANHES 2007–2008). Arch Osteoporos 2012;7:291-9. [DOI: 10.1007/s11657-012-0111-2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
128 Haines ML, Anderson RP, Gibson PR. Systematic review: The evidence base for long-term management of coeliac disease. Aliment Pharmacol Ther. 2008;28:1042-1066. [PMID: 18671779 DOI: 10.1111/j.1365-2036.2008.03820.x] [Cited by in Crossref: 124] [Cited by in F6Publishing: 116] [Article Influence: 8.9] [Reference Citation Analysis]
129 McGough N, Cummings JH. Coeliac disease: a diverse clinical syndrome caused by intolerance of wheat, barley and rye. Proc Nutr Soc 2005;64:434-50. [PMID: 16313685 DOI: 10.1079/pns2005461] [Cited by in Crossref: 46] [Cited by in F6Publishing: 9] [Article Influence: 2.9] [Reference Citation Analysis]
130 Paik JM, Rosen HN, Gordon CM, Curhan GC. Diuretic Use and Risk of Vertebral Fracture in Women. Am J Med 2016;129:1299-306. [PMID: 27542612 DOI: 10.1016/j.amjmed.2016.07.013] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 3.5] [Reference Citation Analysis]
131 Moreno ML, Vazquez H, Mazure R, Smecuol E, Niveloni S, Pedreira S, Sugai E, Mauriño E, Gomez JC, Bai JC. Stratification of bone fracture risk in patients with celiac disease. Clin Gastroenterol Hepatol 2004;2:127-34. [PMID: 15017617 DOI: 10.1016/s1542-3565(03)00320-3] [Cited by in Crossref: 50] [Cited by in F6Publishing: 20] [Article Influence: 2.8] [Reference Citation Analysis]
132 Oh HJ, Ryu KH, Park BJ, Yoon BH. Osteoporosis and Osteoporotic Fractures in Gastrointestinal Disease. J Bone Metab 2018;25:213-7. [PMID: 30574465 DOI: 10.11005/jbm.2018.25.4.213] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
133 Davie MW, Gaywood I, George E, Jones PW, Masud T, Price T, Summers GD. Excess non-spine fractures in women over 50 years with celiac disease: a cross-sectional, questionnaire-based study. Osteoporos Int 2005;16:1150-5. [PMID: 15692728 DOI: 10.1007/s00198-004-1822-z] [Cited by in Crossref: 34] [Cited by in F6Publishing: 28] [Article Influence: 2.0] [Reference Citation Analysis]
134 Rejnmark L, Vestergaard P, Mosekilde L. Fracture risk in patients treated with amiodarone or digoxin for cardiac arrhythmias: a nation-wide case-control study. Osteoporos Int 2007;18:409-17. [DOI: 10.1007/s00198-006-0250-7] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
135 Goodhand JR, Kamperidis N, Nguyen H, Wahed M, Rampton DS. Application of the WHO fracture risk assessment tool (FRAX) to predict need for DEXA scanning and treatment in patients with inflammatory bowel disease at risk of osteoporosis. Aliment Pharmacol Ther. 2011;33:551-558. [PMID: 21198706 DOI: 10.1111/j.1365-2036.2010.04554.x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
136 Vestergaard P, Rejnmark L, Mosekilde L. Fracture risk associated with parkinsonism and anti-Parkinson drugs. Calcif Tissue Int 2007;81:153-61. [PMID: 17705047 DOI: 10.1007/s00223-007-9065-6] [Cited by in Crossref: 62] [Cited by in F6Publishing: 49] [Article Influence: 4.1] [Reference Citation Analysis]
137 Hallas J, Pottegård A, Wang S, Schneeweiss S, Gagne JJ. Persistent User Bias in Case-Crossover Studies in Pharmacoepidemiology. Am J Epidemiol 2016;184:761-9. [DOI: 10.1093/aje/kww079] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 3.8] [Reference Citation Analysis]
138 Schoon EJ, Bollani S, Mills PR, Israeli E, Felsenberg D, Ljunghall S, Persson T, Haptén-White L, Graffner H, Bianchi Porro G, Vatn M, Stockbrügger RW; Matrix Study Group. Bone mineral density in relation to efficacy and side effects of budesonide and prednisolone in Crohn's disease. Clin Gastroenterol Hepatol 2005;3:113-21. [PMID: 15704045 DOI: 10.1016/s1542-3565(04)00662-7] [Cited by in Crossref: 108] [Cited by in F6Publishing: 23] [Article Influence: 6.4] [Reference Citation Analysis]
139 Safipour Z, van der Zanden R, van den Bergh J, Janssen P, Vestergaard P, de Vries F, Driessen JHM. The use of oral glucocorticoids and the risk of major osteoporotic fracture in patients with myasthenia gravis. Osteoporos Int 2021. [PMID: 34601629 DOI: 10.1007/s00198-021-06101-3] [Reference Citation Analysis]
140 Kwon KA, Ku YS. Can early onset of disease be one of the risk factors for low bone mineral density in patients with inflammatory bowel disease? Clin Endosc 2013;46:5-6. [PMID: 23424712 DOI: 10.5946/ce.2013.46.1.5] [Reference Citation Analysis]
141 Gissel T, Poulsen CS, Vestergaard P. Adverse effects of antiepileptic drugs on bone mineral density in children. Expert Opinion on Drug Safety 2007;6:267-78. [DOI: 10.1517/14740338.6.3.267] [Cited by in Crossref: 29] [Cited by in F6Publishing: 23] [Article Influence: 1.9] [Reference Citation Analysis]
142 Walker MD, Zylberberg HM, Green PHR, Katz MS. Endocrine complications of celiac disease: a case report and review of the literature. Endocr Res 2019;44:27-45. [PMID: 30198791 DOI: 10.1080/07435800.2018.1509868] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
143 Kruse C, Eiken P, Vestergaard P. Continuous and long-term treatment is more important than dosage for the protective effect of thiazide use on bone metabolism and fracture risk. J Intern Med 2016;279:110-22. [PMID: 26223424 DOI: 10.1111/joim.12397] [Cited by in Crossref: 14] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
144 Petersen SB, Olsen SF, Mølgaard C, Granström C, Cohen A, Vestergaard P, Strøm M. Maternal vitamin D status and offspring bone fractures: prospective study over two decades in Aarhus City, Denmark. PLoS One 2014;9:e114334. [PMID: 25474409 DOI: 10.1371/journal.pone.0114334] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
145 Rubin KH, Abrahamsen B, Hermann AP, Bech M, Gram J, Brixen K. Fracture risk assessed by Fracture Risk Assessment Tool (FRAX) compared with fracture risk derived from population fracture rates. Scand J Public Health 2011;39:312-8. [PMID: 21429990 DOI: 10.1177/1403494811402412] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
146 Fouda MA, Khan AA, Sultan MS, Rios LP, McAssey K, Armstrong D. Evaluation and management of skeletal health in celiac disease: position statement. Can J Gastroenterol 2012;26:819-29. [PMID: 23166906 DOI: 10.1155/2012/823648] [Cited by in Crossref: 33] [Cited by in F6Publishing: 25] [Article Influence: 3.7] [Reference Citation Analysis]
147 Rastogi A, Bhadada SK, Bhansali A, Kochhar R, Santosh R. Celiac disease: A missed cause of metabolic bone disease. Indian J Endocrinol Metab 2012;16:780-5. [PMID: 23087864 DOI: 10.4103/2230-8210.100674] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
148 West J, Logan RF, Card TR, Smith C, Hubbard R. Fracture risk in people with celiac disease: a population-based cohort study. Gastroenterology. 2003;125:429-436. [PMID: 12891545 DOI: 10.1016/s0016-5085(03)00891-6] [Cited by in Crossref: 126] [Cited by in F6Publishing: 46] [Article Influence: 6.6] [Reference Citation Analysis]
149 Hansen L, Petersen KD, Eriksen SA, Langdahl BL, Eiken PA, Brixen K, Abrahamsen B, Jensen JE, Harsløf T, Vestergaard P. Subsequent fracture rates in a nationwide population-based cohort study with a 10-year perspective. Osteoporos Int 2015;26:513-9. [PMID: 25187120 DOI: 10.1007/s00198-014-2875-2] [Cited by in Crossref: 36] [Cited by in F6Publishing: 25] [Article Influence: 4.5] [Reference Citation Analysis]
150 Ludvigsson JF, Murray JA. Epidemiology of Celiac Disease. Gastroenterol Clin North Am. 2019;48:1-18. [PMID: 30711202 DOI: 10.1016/j.gtc.2018.09.004] [Cited by in Crossref: 45] [Cited by in F6Publishing: 39] [Article Influence: 11.3] [Reference Citation Analysis]
151 Jakob F. [Primary and secondary osteoporosis. The important role of internal medicine in its differential diagnosis]. Internist (Berl) 2005;46 Suppl 1:S24-30. [PMID: 15846478 DOI: 10.1007/s00108-005-1417-6] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
152 Sylvester FA. Do bones crack under the effects of inflammatory bowel disease in children? J Pediatr Gastroenterol Nutr 2006;43:563-5. [PMID: 17130728 DOI: 10.1097/01.mpg.0000239736.64240.3b] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
153 Krupa-Kozak U. Pathologic bone alterations in celiac disease: etiology, epidemiology, and treatment. Nutrition. 2014;30:16-24. [PMID: 24290593 DOI: 10.1016/j.nut.2013.05.027] [Cited by in Crossref: 46] [Cited by in F6Publishing: 41] [Article Influence: 5.8] [Reference Citation Analysis]
154 Bernstein CN, Blanchard JF, Metge C, Yogendran M. The association between corticosteroid use and development of fractures among IBD patients in a population-based database. Am J Gastroenterol. 2003;98:1797-1801. [PMID: 12907335 DOI: 10.1111/j.1572-0241.2003.07590.x] [Cited by in Crossref: 45] [Cited by in F6Publishing: 41] [Article Influence: 2.4] [Reference Citation Analysis]
155 Vestergaard P, Rejnmark L, Mosekilde L. Anxiolytics, sedatives, antidepressants, neuroleptics and the risk of fracture. Osteoporos Int 2006;17:807-16. [DOI: 10.1007/s00198-005-0065-y] [Cited by in Crossref: 127] [Cited by in F6Publishing: 121] [Article Influence: 7.9] [Reference Citation Analysis]
156 Cashman KD. Altered bone metabolism in inflammatory disease: role for nutrition: Symposium on ‘Diet and bone health’. Proc Nutr Soc 2008;67:196-205. [DOI: 10.1017/s0029665108007039] [Cited by in Crossref: 16] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
157 Kanis JA, Johnell O, Oden A, Johansson H, McCloskey E. FRAX and the assessment of fracture probability in men and women from the UK. Osteoporos Int. 2008;19:385-397. [PMID: 18292978 DOI: 10.1007/s00198-007-0543-5] [Cited by in Crossref: 1423] [Cited by in F6Publishing: 1215] [Article Influence: 101.6] [Reference Citation Analysis]
158 Jensen MH, Hejlesen O, Vestergaard P. Association of insulin regimens with severe hypoglycaemia in patients with type 1 diabetes: A Danish case-control study. Br J Clin Pharmacol 2020;86:1560-6. [PMID: 32086824 DOI: 10.1111/bcp.14263] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
159 Ramakrishna BS, Makharia GK, Abraham P, Ghoshal UC, Jayanthi V, Agarwal BK, Ahuja V, Bhasin DK, Bhatia SJ, Choudhuri G. Indian Society of Gastroenterology consensus on ulcerative colitis. Indian J Gastroenterol. 2012;31:307-323. [PMID: 23096266 DOI: 10.1007/s12664-012-0259-0] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 2.2] [Reference Citation Analysis]
160 Rostom A, Murray JA, Kagnoff MF. American Gastroenterological Association (AGA) Institute Technical Review on the Diagnosis and Management of Celiac Disease. Gastroenterology 2006;131:1981-2002. [DOI: 10.1053/j.gastro.2006.10.004] [Cited by in Crossref: 447] [Cited by in F6Publishing: 393] [Article Influence: 27.9] [Reference Citation Analysis]
161 Hartman C, Hino B, Lerner A, Eshach-Adiv O, Berkowitz D, Shaoul R, Pacht A, Rozenthal E, Tamir A, Shamaly H. Bone quantitative ultrasound and bone mineral density in children with celiac disease. J Pediatr Gastroenterol Nutr. 2004;39:504-510. [PMID: 15572890 DOI: 10.1097/00005176-200411000-00011] [Cited by in Crossref: 37] [Cited by in F6Publishing: 35] [Article Influence: 2.2] [Reference Citation Analysis]
162 Moosgaard B, Christensen SE, Vestergaard P, Heickendorff L, Christiansen P, Mosekilde L. Vitamin D metabolites and skeletal consequences in primary hyperparathyroidism. Clin Endocrinol (Oxf) 2008;68:707-15. [PMID: 17980013 DOI: 10.1111/j.1365-2265.2007.03109.x] [Cited by in Crossref: 51] [Cited by in F6Publishing: 39] [Article Influence: 3.4] [Reference Citation Analysis]
163 Canova C, Pitter G, Zanier L, Simonato L, Michaelsson K, Ludvigsson JF. Risk of Fractures in Youths with Celiac Disease-A Population-Based Study. J Pediatr 2018;198:117-20. [PMID: 29681452 DOI: 10.1016/j.jpeds.2018.02.070] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
164 Petersen SB, Rasmussen MA, Olsen SF, Vestergaard P, Mølgaard C, Halldorsson TI, Strøm M. Maternal dietary patterns during pregnancy in relation to offspring forearm fractures: prospective study from the Danish National Birth Cohort. Nutrients 2015;7:2382-400. [PMID: 25849947 DOI: 10.3390/nu7042382] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 2.7] [Reference Citation Analysis]
165 Vestergaard P, Rejnmark L, Mosekilde L. Proton pump inhibitors, histamine H2 receptor antagonists, and other antacid medications and the risk of fracture. Calcif Tissue Int. 2006;79:76-83. [PMID: 16927047 DOI: 10.1007/s00223-006-0021-7] [Cited by in Crossref: 262] [Cited by in F6Publishing: 206] [Article Influence: 16.4] [Reference Citation Analysis]
166 Vestergaard P, Rejnmark L, Mosekilde L. Diabetes and its complications and their relationship with risk of fractures in type 1 and 2 diabetes. Calcif Tissue Int 2009;84:45-55. [PMID: 19067021 DOI: 10.1007/s00223-008-9195-5] [Cited by in Crossref: 172] [Cited by in F6Publishing: 142] [Article Influence: 12.3] [Reference Citation Analysis]
167 Vestergaard P, Rejnmark L, Mosekilde L. Selective serotonin reuptake inhibitors and other antidepressants and risk of fracture. Calcif Tissue Int 2008;82:92-101. [PMID: 18219438 DOI: 10.1007/s00223-007-9099-9] [Cited by in Crossref: 70] [Cited by in F6Publishing: 59] [Article Influence: 5.0] [Reference Citation Analysis]
168 Vestergaard P, Rejnmark L, Mosekilde L. Relative fracture risk in patients with diabetes mellitus, and the impact of insulin and oral antidiabetic medication on relative fracture risk. Diabetologia. 2005;48:1292-1299. [PMID: 15909154 DOI: 10.1007/s00125-005-1786-3] [Cited by in Crossref: 366] [Cited by in F6Publishing: 307] [Article Influence: 21.5] [Reference Citation Analysis]
169 Bernstein CN, Bector S, Leslie WD. Lack of relationship of calcium and vitamin D intake to bone mineral density in premenopausal women with inflammatory bowel disease. Am J Gastroenterol. 2003;98:2468-2473. [PMID: 14638350 DOI: 10.1111/j.1572-0241.2003.07676.x] [Cited by in Crossref: 35] [Cited by in F6Publishing: 36] [Article Influence: 1.9] [Reference Citation Analysis]
170 Lee N, Radford-Smith G, Taaffe DR. Bone loss in Crohn’s disease: exercise as a potential countermeasure. Inflamm Bowel Dis. 2005;11:1108-1118. [PMID: 16306774 DOI: 10.1097/01.mib.0000192325.28168.08] [Cited by in Crossref: 22] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
171 Castro B, Rivero M, Crespo J, Riancho JA, Valero C. Influence of anti-TNF therapy on bone metabolism in patients with inflammatory bowel disease. European Journal of Internal Medicine 2017;39:e33-4. [DOI: 10.1016/j.ejim.2017.01.024] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
172 Blaschke M, Koepp R, Lenz C, Kruppa J, Jung K, Siggelkow H. Crohn's disease patient serum changes protein expression in a human mesenchymal stem cell model in a linear relationship to patients' disease stage and to bone mineral density. J Clin Transl Endocrinol 2018;13:26-38. [PMID: 30003044 DOI: 10.1016/j.jcte.2018.06.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
173 Painter SE, Kleerekoper M, Camacho PM. Secondary osteoporosis: a review of the recent evidence. Endocr Pract 2006;12:436-45. [PMID: 16901802 DOI: 10.4158/EP.12.4.436] [Cited by in Crossref: 82] [Cited by in F6Publishing: 25] [Article Influence: 5.1] [Reference Citation Analysis]
174 Williams H, Walker D, Orchard TR. Extraintestinal manifestations of inflammatory bowel disease. Curr Gastroenterol Rep. 2008;10:597-605. [PMID: 19006617 DOI: 10.1007/s11894-008-0108-6] [Cited by in Crossref: 50] [Cited by in F6Publishing: 50] [Article Influence: 3.8] [Reference Citation Analysis]
175 Vestergaard P, Rejnmark L, Mosekilde L. Socioeconomic aspects of fractures within universal public healthcare: A nationwide case-control study from Denmark. Scand J Public Health 2006;34:371-7. [DOI: 10.1080/14034940500441223] [Cited by in Crossref: 46] [Cited by in F6Publishing: 44] [Article Influence: 7.7] [Reference Citation Analysis]
176 Jafri MR, Nordstrom CW, Murray JA, Van Dyke CT, Dierkhising RA, Zinsmeister AR, Melton LJ 3rd. Long-term fracture risk in patients with celiac disease: a population-based study in Olmsted County, Minnesota. Dig Dis Sci 2008;53:964-71. [PMID: 17934823 DOI: 10.1007/s10620-007-9976-0] [Cited by in Crossref: 58] [Cited by in F6Publishing: 48] [Article Influence: 3.9] [Reference Citation Analysis]
177 Ludvigsson JF, Bai JC, Biagi F, Card TR, Ciacci C, Ciclitira PJ, Green PH, Hadjivassiliou M, Holdoway A, van Heel DA, Kaukinen K, Leffler DA, Leonard JN, Lundin KE, McGough N, Davidson M, Murray JA, Swift GL, Walker MM, Zingone F, Sanders DS; BSG Coeliac Disease Guidelines Development Group., British Society of Gastroenterology. Diagnosis and management of adult coeliac disease: guidelines from the British Society of Gastroenterology. Gut 2014;63:1210-28. [PMID: 24917550 DOI: 10.1136/gutjnl-2013-306578] [Cited by in Crossref: 546] [Cited by in F6Publishing: 475] [Article Influence: 68.3] [Reference Citation Analysis]
178 Ronca E, Scheel-Sailer A, Koch HG, Metzger S, Gemperli A. Inpatient migration patterns in persons with spinal cord injury: A registry study with hospital discharge data. SSM Popul Health 2016;2:259-68. [PMID: 29349146 DOI: 10.1016/j.ssmph.2016.04.004] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
179 Vázquez MA, Lopez E, Montoya MJ, Giner M, Pérez-Temprano R, Pérez-Cano R. Vertebral fractures in patients with inflammatory bowel disease compared with a healthy population: a prospective case-control study. BMC Gastroenterol 2012;12:47. [PMID: 22584049 DOI: 10.1186/1471-230X-12-47] [Cited by in Crossref: 27] [Cited by in F6Publishing: 11] [Article Influence: 2.7] [Reference Citation Analysis]
180 Terzoudis S, Zavos C, Koutroubakis IE. The bone and fat connection in inflammatory bowel diseases. Inflamm Bowel Dis. 2014;20:2207-2217. [PMID: 24983981 DOI: 10.1097/mib.0000000000000111] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
181 Ludvigsson JF, Green PH. Clinical management of coeliac disease. J Intern Med. 2011;269:560-571. [PMID: 21443532 DOI: 10.1111/j.1365-2796.2011.02379.x] [Cited by in Crossref: 70] [Cited by in F6Publishing: 68] [Article Influence: 6.4] [Reference Citation Analysis]
182 Adler RA, Curtis J, Weinstein RS, Saag KG. Glucocorticoid-Induced Osteoporosis. Osteoporosis. Elsevier; 2008. pp. 1135-66. [DOI: 10.1016/b978-012370544-0.50046-x] [Cited by in Crossref: 9] [Article Influence: 0.6] [Reference Citation Analysis]
183 Vestergaard P, Schwartz F, Rejnmark L, Mosekilde L. Risk of femoral shaft and subtrochanteric fractures among users of bisphosphonates and raloxifene. Osteoporos Int 2011;22:993-1001. [DOI: 10.1007/s00198-010-1512-y] [Cited by in Crossref: 47] [Cited by in F6Publishing: 36] [Article Influence: 3.9] [Reference Citation Analysis]
184 Kruse C, Eiken P, Verbalis J, Vestergaard P. The effect of chronic mild hyponatremia on bone mineral loss evaluated by retrospective national Danish patient data. Bone 2016;84:9-14. [PMID: 26679436 DOI: 10.1016/j.bone.2015.12.002] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 2.1] [Reference Citation Analysis]
185 Holm JP, Amar AOS, Hyldstrup L, Jensen JEB. Hyponatremia, a risk factor for osteoporosis and fractures in women. Osteoporos Int 2016;27:989-1001. [DOI: 10.1007/s00198-015-3370-0] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.9] [Reference Citation Analysis]
186 Oshagbemi OA, Driessen JHM, Pieffers A, Wouters EFM, Geusens P, Vestergaard P, van den Bergh J, Franssen FME, de Vries F. Use of systemic glucocorticoids and the risk of major osteoporotic fractures in patients with sarcoidosis. Osteoporos Int 2017;28:2859-66. [PMID: 28638981 DOI: 10.1007/s00198-017-4115-z] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
187 Vestergaard P, Prieto-Alhambra D, Javaid MK, Cooper C. Fractures in users of antidepressants and anxiolytics and sedatives: effects of age and dose. Osteoporos Int 2013;24:671-80. [PMID: 22669469 DOI: 10.1007/s00198-012-2043-5] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 2.7] [Reference Citation Analysis]
188 Mauro M, Radovic V, Armstrong D. Improvement of lumbar bone mass after infliximab therapy in Crohn's disease patients. Can J Gastroenterol 2007;21:637-42. [PMID: 17948133 DOI: 10.1155/2007/216162] [Cited by in Crossref: 33] [Cited by in F6Publishing: 25] [Article Influence: 2.4] [Reference Citation Analysis]
189 Prieto-alhambra D, Güerri-fernández R, De Vries F, Lalmohamed A, Bazelier M, Starup-linde J, Diez-perez A, Cooper C, Vestergaard P. HIV Infection and Its Association With an Excess Risk of Clinical Fractures: A Nationwide Case–Control Study. JAIDS Journal of Acquired Immune Deficiency Syndromes 2014;66:90-5. [DOI: 10.1097/qai.0000000000000112] [Cited by in Crossref: 64] [Cited by in F6Publishing: 26] [Article Influence: 8.0] [Reference Citation Analysis]
190 Driessen JH, van Onzenoort HA, Starup-Linde J, Henry R, Neef C, van den Bergh J, Vestergaard P, de Vries F, Burden AM. Use of dipeptidyl peptidase 4 inhibitors and fracture risk compared to use of other anti-hyperglycemic drugs. Pharmacoepidemiol Drug Saf. 2015;24:1017-1025. [PMID: 26183226 DOI: 10.1002/pds.3837] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 3.4] [Reference Citation Analysis]
191 Rejnmark L, Vestergaard P, Mosekilde L. Fracture risk in patients treated with loop diuretics. J Intern Med 2006;259:117-24. [DOI: 10.1111/j.1365-2796.2005.01585.x] [Cited by in Crossref: 56] [Cited by in F6Publishing: 48] [Article Influence: 3.5] [Reference Citation Analysis]
192 Rubin KH, Glintborg D, Nybo M, Andersen M, Abrahamsen B. Fracture Risk Is Decreased in Women With Polycystic Ovary Syndrome: A Register‐Based and Population‐Based Cohort Study. J Bone Miner Res 2016;31:709-17. [DOI: 10.1002/jbmr.2737] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
193 Di Stefano M, Mengoli C, Bergonzi M, Corazza GR. Bone mass and mineral metabolism alterations in adult celiac disease: pathophysiology and clinical approach. Nutrients 2013;5:4786-99. [PMID: 24284619 DOI: 10.3390/nu5114786] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 3.1] [Reference Citation Analysis]
194 Vestergaard P, Rejnmark L, Mosekilde L. Fracture risk associated with different types of oral corticosteroids and effect of termination of corticosteroids on the risk of fractures. Calcif Tissue Int 2008;82:249-57. [PMID: 18414920 DOI: 10.1007/s00223-008-9124-7] [Cited by in Crossref: 50] [Cited by in F6Publishing: 38] [Article Influence: 3.6] [Reference Citation Analysis]
195 Leboff MS, Cobb H, Gao LY, Hawkes W, Yu-Yahiro J, Kolatkar NS, Magaziner J. Celiac disease is not increased in women with hip fractures and low vitamin D levels. J Nutr Health Aging 2013;17:562-5. [PMID: 23732553 DOI: 10.1007/s12603-013-0017-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
196 Lippuner K, Johansson H, Kanis JA, Rizzoli R. FRAX® assessment of osteoporotic fracture probability in Switzerland. Osteoporos Int 2010;21:381-9. [DOI: 10.1007/s00198-009-0975-1] [Cited by in Crossref: 75] [Cited by in F6Publishing: 66] [Article Influence: 5.8] [Reference Citation Analysis]
197 Lee JS, Lee HS, Jang BI, Kim ES, Kim SK, Kim KO, Lee YJ, Lee HJ, Kim EY, Jung YJ, Yang CH; Crohn’s and Colitis Association in Daegu-Gyeongbuk (CCAiD). Low Bone Mineral Density in Young Patients Newly Diagnosed with Inflammatory Bowel Disease. Dig Dis Sci 2021;66:605-11. [PMID: 32222926 DOI: 10.1007/s10620-020-06220-7] [Reference Citation Analysis]
198 Vestergaard P, Rejnmark L, Mosekilde L. Fracture risk associated with systemic and topical corticosteroids: CORTICOSTEROIDS AND FRACTURES. Journal of Internal Medicine 2005;257:374-84. [DOI: 10.1111/j.1365-2796.2005.01467.x] [Cited by in Crossref: 67] [Cited by in F6Publishing: 57] [Article Influence: 3.9] [Reference Citation Analysis]
199 Vestergaard P, Rejnmark L, Mosekilde L. Osteoarthritis and risk of fractures. Calcif Tissue Int 2009;84:249-56. [PMID: 19234808 DOI: 10.1007/s00223-009-9224-z] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 2.3] [Reference Citation Analysis]
200 Compston J. Is fracture risk increased in patients with coeliac disease? Gut 2003;52:459-60. [PMID: 12631649 DOI: 10.1136/gut.52.4.459] [Cited by in Crossref: 25] [Cited by in F6Publishing: 19] [Article Influence: 1.3] [Reference Citation Analysis]
201 Siffledeen JS, Fedorak RN, Siminoski K, Jen H, Vaudan E, Abraham N, Steinhart H, Greenberg G. Randomized trial of etidronate plus calcium and vitamin D for treatment of low bone mineral density in Crohn’s disease. Clinical Gastroenterology and Hepatology 2005;3:122-32. [DOI: 10.1016/s1542-3565(04)00663-9] [Cited by in Crossref: 60] [Cited by in F6Publishing: 13] [Article Influence: 3.5] [Reference Citation Analysis]
202 Azzopardi N, Ellul P. Risk factors for osteoporosis in Crohn's disease: infliximab, corticosteroids, body mass index, and age of onset. Inflamm Bowel Dis. 2013;19:1173-1178. [PMID: 23511037 DOI: 10.1097/mib.0b013e31828075a7] [Cited by in Crossref: 27] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
203 Ewid M, Al Mutiri N, Al Omar K, Shamsan AN, Rathore AA, Saquib N, Salaas A, Al Sarraj O, Nasri Y, Attal A, Tawfiq A, Sherif H. Updated bone mineral density status in Saudi patients with inflammatory bowel disease. World J Gastroenterol 2020; 26(35): 5343-5353 [PMID: 32994692 DOI: 10.3748/wjg.v26.i35.5343] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
204 Jatla M, Zemel BS, Bierly P, Verma R. Bone mineral content deficits of the spine and whole body in children at time of diagnosis with celiac disease. J Pediatr Gastroenterol Nutr 2009;48:175-80. [PMID: 19179879 DOI: 10.1097/MPG.0b013e318177e621] [Cited by in Crossref: 17] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
205 Walker MD, Williams J, Lewis SK, Bai JC, Lebwohl B, Green PHR. Measurement of Forearm Bone Density by Dual Energy X-Ray Absorptiometry Increases the Prevalence of Osteoporosis in Men With Celiac Disease. Clin Gastroenterol Hepatol 2020;18:99-106. [PMID: 30981003 DOI: 10.1016/j.cgh.2019.03.049] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
206 Vestergaard P, Rejnmark L, Mosekilde L. Fracture risk in patients with chronic lung diseases treated with bronchodilator drugs and inhaled and oral corticosteroids. Chest 2007;132:1599-607. [PMID: 17890464 DOI: 10.1378/chest.07-1092] [Cited by in Crossref: 49] [Cited by in F6Publishing: 46] [Article Influence: 3.3] [Reference Citation Analysis]
207 Lix LM, Quail J, Teare G, Acan B. Performance of comorbidity measures for predicting outcomes in population-based osteoporosis cohorts. Osteoporos Int 2011;22:2633-43. [DOI: 10.1007/s00198-010-1516-7] [Cited by in Crossref: 21] [Cited by in F6Publishing: 25] [Article Influence: 1.9] [Reference Citation Analysis]
208 Miheller P, Lőrinczy K, Lakatos PL. Clinical relevance of changes in bone metabolism in inflammatory bowel disease. World J Gastroenterol 2010; 16(44): 5536-5542 [PMID: 21105186 DOI: 10.3748/wjg.v16.i44.5536] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
209 Rejnmark L, Vestergaard P, Mosekilde L. Fracture risk in users of oral anticoagulants: a nationwide case-control study. Int J Cardiol 2007;118:338-44. [PMID: 17055083 DOI: 10.1016/j.ijcard.2006.07.022] [Cited by in Crossref: 32] [Cited by in F6Publishing: 25] [Article Influence: 2.0] [Reference Citation Analysis]
210 Stokkers PC, Deley M, Van Der Spek M, Verberne HJ, Van Deventer SJ, Hommes DW. Intravenous pamidronate in combination with calcium and vitamin D: highly effective in the treatment of low bone mineral density in inflammatory bowel disease. Scand J Gastroenterol. 2006;41:200-204. [PMID: 16484125 DOI: 10.1080/00365520500206467] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
211 Bernstein CN, Leslie WD. Therapy Insight: osteoporosis in inflammatory bowel disease—advances and retreats. Nat Rev Gastroenterol Hepatol 2005;2:232-9. [DOI: 10.1038/ncpgasthep0169] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 0.8] [Reference Citation Analysis]
212 Reyes García R, Jódar Gimeno E, García Martín A, Romero Muñoz M, Gómez Sáez JM, Luque Fernández I, Varsavsky M, Guadalix Iglesias S, Cano Rodriguez I, Ballesteros Pomar MD, Vidal Casariego A, Rozas Moreno P, Cortés Berdonces M, Fernández García D, Calleja Canelas A, Palma Moya M, Martínez Díaz-guerra G, Jimenez Moleón JJ, Muñoz Torres M. Guías de práctica clínica para la evaluación y tratamiento de la osteoporosis asociada a enfermedades endocrinas y nutricionales. Endocrinología y Nutrición 2012;59:174-96. [DOI: 10.1016/j.endonu.2012.01.002] [Cited by in Crossref: 17] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]